PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size, Trends, Share, Growth, and Opportunity Forecast, 2023 - 2030 Global Industry Analysis By Drug Type (Olaparib, Niraparib, Rucaparib, Talazoparib, Veliparib, and Others), By Indication (Breast Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic Cancer, Others), By End-user (Hospitals, Specialty Clinics, Homecare, Others), By Sales Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)
Region: Global
Published: December 2023
Report Code: CGNPHR137
Pages: 174